Menu
ABOUT
ABOUT
1
The main objective of the CorEuStem is to develop an efficient and effective consortium for harmonizing procedures, protocols and tools to provide efficient benchmarking, quality control and intensive training.
2
One of the major challenges for core facilities is to keep track, evaluate and implement cutting-edge technologies. Core facilities strive to standardize, evaluate, adopt and implement new technologies in the field of hPSCs, organoid biology and gene editing
3
In the past 12 years, experimental approaches used in biomedical research have been reshaped by the discovery of human induced pluripotent stem cells (iPSCs), the development of CRISPR/Cas9 gene editing technology and the possibility of generating in vitro organ-like structures called organoids.
Structure
Join the action
The COST Action CorEuStem welcomes research-active scientists working in the field. There are many ways to get involved.
News
Kick starting 2025 with Our First Webinar organized by WG1! Title: Transient Naive Treatment (TNT) Reprogramming iPSC Date: 20 February 2025 Time: 10:00 CET Location: Zoom (Zoom link will be sent the day before the event)) The Transient Naive Treatment (TNT) reprogramming method, which briefly introduces naive media early in the reprogramming process, effectively erases epigenetic memory and produces...
We would like to invite all CorEuStem members to the webinar “Modelling Human Disease using iPSC and Genome Engineering” 🗓 Date: December 19th, 2024 🕚 Time: 10:00 AM (CET) 👩🔬 Speaker: Dr. Andrea Rossi – Group Leader, Environmental Adaptation and Cellular Resilience Laboratory. Head of the Genome Engineering and Model Development (GEMD) Core Unit at...
WG2 is pleased to announce a Q&A session on Crisper Cas9 Genome Engineering, where you can get answers to all your questions and engage directly with experts from different research institutes: Narasimha Telugu, Ralf Kühn, Justin McDonough, Bernhard Schmierer, Carol Jennifer and Pia Johansson. Date: December 5th Time: 4:00 pm CET Location: Zoom Whether you’re looking for clarity on...
We are pleased to invite you to the upcoming CorEuStem WG2 webinar: 🗓 Date: December 12th, 2024🕚 Time: 11:00 CET👩🔬 Speaker: Vanessa QUILLAUD-CHENOUARD, Post-doctorate researcher🌍 Affiliation: Nantes Université, INSERM, Center for Research in Transplantation and Translational Immunology (UMR 1064), Nantes, France About the speaker:Vanessa Quillaud-Chenouard holds a PhD in molecular biology and is currently a post-doctorate researcher at the Center for Research in Transplantation...
Last September, the second WG4 hands-on training event took place at Erasmus Medical Centre, attracting experts to discuss innovative tissue modelling methodologies, from hematopoietic stem cell differentiation to advanced brain organoid models. The event opened with a welcome address by the host Mehrnaz Ghazvini (Erasmus MC, Rotterdam, Netherlands), followed by insightful presentations from Andrea Ditadi...
Last October 9th the core group of CorEuStem COST Action got together in Riga, Latvia. Hosted by Professor Una Riekstina, WG4 co-leader, the meeting covered the sustainability of the Core Facilities Network to upcoming years, upcoming activities and manuscripts planned for the last year of the Action, and potential grant applications for the future.
COST (European Cooperation in Science and Technology) is a funding organisation for research and innovation networks. Our Actions help connect research initiatives across Europe and beyond and enable researchers and innovators to grow their ideas in any science and technology field by sharing them with their peers. COST Actions are bottom-up networks with a duration of four years that boost research, innovation and careers.
The COST Action CorEuStem will be comprised of European core facilities that are experts in stem cell biology, differentiation, organoids and gene editing technologies with the aim of developing an efficient and effective consortium for harmonizing procedures and protocols across Europe and beyond.
MoU • Memorandum of Understanding
CSO Approval date: 25 May 2021
Action start date: 21 October 2021
Action end date: 20 October 2025
